Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
Using a lower volume of bacteriostatic water produces a more concentrated solution (smaller injection volume per dose)
Egrifta and the related Egrifta SV and Egrifta WR formulations are Health Canada-approved or FDA-approved prescription drug products manufactured to pharmaceutical standards and supplied for human therapeutic use under prescription
Possible redness, swelling, or small knot formation can occur and typically resolves within several days
A beneficial human NAD effect has not been demonstrated
A Certificate of Analysis is available for each batch, with lot and expiry details
Immune Modulation and Inflammation Calming the chronic immune activation driving long COVID symptoms without suppressing immune function is a nuanced goal
US$ 27.77
US$ 27.73
US$ 28.62
US$ 25.84
